TickerStat.comwe like data

Acumen Pharmaceuticals Shares Outstanding History (ABOS)

Acumen Pharmaceuticals reported 60.6M shares outstanding at the end of fiscal 2025.

View full Acumen Pharmaceuticals company overview

Acumen Pharmaceuticals annual shares outstanding history

Acumen Pharmaceuticals annual shares outstanding

Fiscal yearPeriod endedShares outstandingChangeGrowth
20252025-12-3160.6M481,286+0.80%
20242024-12-3160.1M2.2M+3.77%
20232023-12-3157.9M16.9M+41.16%
20222022-12-3141.0M551,792+1.36%
20212021-12-3140.5M40.1M+9556.63%
20202020-12-31419,124——

Acumen Pharmaceuticals Share Buyback History

A share buyback, also called a stock repurchase, is when a company uses cash to buy its own shares. Acumen Pharmaceuticals share buyback history shows the reported cash used for repurchases. Buybacks can reduce shares outstanding, but issuance, stock-based compensation, acquisitions, and stock splits can change the share count separately.

Acumen Pharmaceuticals used $73,000 to repurchase common stock in fy 2025. Across the latest 3 reported fiscal years, total share repurchases were $114,000. The latest reported quarter showed $0 of share repurchases.

Acumen Pharmaceuticals annual share buyback history
Fiscal yearPeriod endedShare repurchases
20252025-12-31$73,000
20242024-12-31$41,000
20232023-12-31$0

TickerStat uses SEC-reported cash payments for common-stock repurchases. The amounts describe capital returned through buybacks; they are not a forecast or a measure of the number of shares retired.

Acumen Pharmaceuticals shares outstanding trends

Over the last five fiscal years, Acumen Pharmaceuticals's shares outstanding moved from 419,124 to 60.6M, a change of 60.2M. The latest reported quarter, Q2 2026, shows 72.3M.

About the metric

What shares outstanding means

Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.

Calculation and source

SEC-reported period-end shares

TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when a stock-split conversion ratio is reported directly or evidenced by a later filing’s restated historical share balance. After repeated reverse splits, an old period can represent less than one current-basis share; this is a split-adjusted equivalent, not a literal historical certificate count. Values remain as reported when no reliable split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Acumen Pharmaceuticals source filings ↗

Community posts

View community